Controls Needed for the Dupuytren Biomarker Discovery Pilot Study
source: pixabay.com

Controls Needed for the Dupuytren Biomarker Discovery Pilot Study

We need controls! No, not cockpit controls or videogame controls, and no, we're not out of control. We need control participants for the Dupuytren Biomarker Discovery Pilot Study. Our goal is…

Continue Reading Controls Needed for the Dupuytren Biomarker Discovery Pilot Study

Former UFC Athlete Joe Ellenberger’s Toughest Opponent: Paroxysmal Nocturnal Hemoglobinuria

The UFC has some tough fighters in it. But 35-year-old Joe Ellenberger never thought that his most difficult opponent would be within himself. That is, his paroxysmal nocturnal hemoglobinuria (PNH),…

Continue Reading Former UFC Athlete Joe Ellenberger’s Toughest Opponent: Paroxysmal Nocturnal Hemoglobinuria
Retevmo Approved for Treatment of Genetically-Mutated Lung and Thyroid Cancers
source: pixabay.com

Retevmo Approved for Treatment of Genetically-Mutated Lung and Thyroid Cancers

A recent BioSpace press release shares some exciting news for patients with non-small cell lung cancer, medullary thyroid cancer, and other thyroid cancers caused by RET gene mutations. Retevmo (selpercatinib) is the…

Continue Reading Retevmo Approved for Treatment of Genetically-Mutated Lung and Thyroid Cancers
UCSF Scientists Use Genes as an On/Off Switch to Fight Autoimmune Diseases and Cancer
source: pixabay.com

UCSF Scientists Use Genes as an On/Off Switch to Fight Autoimmune Diseases and Cancer

  Immunotherapies are in the forefront for treating autoimmune diseases and cancer. Northwestern University and the University of California San Francisco conducted a study using genes that have the potential…

Continue Reading UCSF Scientists Use Genes as an On/Off Switch to Fight Autoimmune Diseases and Cancer
UCSF Scientists Use Genes as an On/Off Switch to Fight Autoimmune Diseases and Cancer
source: pixabay.com

UCSF Scientists Use Genes as an On/Off Switch to Fight Autoimmune Diseases and Cancer

  Immunotherapies are in the forefront for treating autoimmune diseases and cancer. Northwestern University and the University of California San Francisco conducted a study using genes that have the potential…

Continue Reading UCSF Scientists Use Genes as an On/Off Switch to Fight Autoimmune Diseases and Cancer
Treatment for HATTR Amyloidosis Polyneuropathy Approved for Reimbursement in Spain
source: pixabay.com

Treatment for HATTR Amyloidosis Polyneuropathy Approved for Reimbursement in Spain

According to a story from Guru Focus, the biopharmaceutical company Akcea Therapeutics, Inc., an affiliate of Ionis Pharmaceuticals, Inc. recently announced that the Ministry of Health of Spain has cleared…

Continue Reading Treatment for HATTR Amyloidosis Polyneuropathy Approved for Reimbursement in Spain
New Program Will Let Paramedics Visit Chronically Ill Patients Regularly in Their Homes, Reducing ER Visits
source: pixabay.com

New Program Will Let Paramedics Visit Chronically Ill Patients Regularly in Their Homes, Reducing ER Visits

Ocala Fire Rescue Department (OFD) has just launched a "community paramedicine program." The primary aim of this new program is to help keep patients who frequently call 911 out of…

Continue Reading New Program Will Let Paramedics Visit Chronically Ill Patients Regularly in Their Homes, Reducing ER Visits
First Ever Test Which can Predict Progression in Idiopathic Pulmonary Fibrosis is Making Progress
source: pixabay.com

First Ever Test Which can Predict Progression in Idiopathic Pulmonary Fibrosis is Making Progress

Idiopathic Pulmonary Fibrosis Progression Veracyte has just signed a deal with Yale University which will help them develop the very first test which can predict disease progression for idiopathic pulmonary…

Continue Reading First Ever Test Which can Predict Progression in Idiopathic Pulmonary Fibrosis is Making Progress